Covered recipient · General Payments record
ELBA TORRES MATUNDAN
Allopathic & Osteopathic Physicians Pathology Anatomic Pathology & Clinical Pathology
General Payments · PY2018–2024
$8,588.07
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $871.65 | 2 |
| Food and Beverage | $492.19 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Roche Diagnostics Corporation | $1,096.27 | 7 |
| Gilead Sciences, Inc. | $147.21 | 1 |
| DAVOL INC. | $120.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Davol Inc. | $120.36 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127649975 | CMS |
| Gilead Sciences, Inc. | $147.21 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133834264 | CMS |
| Roche Diagnostics Corporation | $737.18 | 09/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089610326 | CMS |
| Roche Diagnostics Corporation | $134.47 | 09/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089610324 | CMS |
| Roche Diagnostics Corporation | $22.30 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089610314 | CMS |
| Roche Diagnostics Corporation | $102.59 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089610322 | CMS |
| Roche Diagnostics Corporation | $23.22 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089610316 | CMS |
| Roche Diagnostics Corporation | $35.71 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089610318 | CMS |
| Roche Diagnostics Corporation | $40.80 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089610320 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.